170 related articles for article (PubMed ID: 22791880)
1. Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma.
Lechner MG; Megiel C; Church CH; Angell TE; Russell SM; Sevell RB; Jang JK; Brody GS; Epstein AL
Clin Cancer Res; 2012 Sep; 18(17):4549-59. PubMed ID: 22791880
[TBL] [Abstract][Full Text] [Related]
2. Breast implant-associated, ALK-negative, T-cell, anaplastic, large-cell lymphoma: establishment and characterization of a model cell line (TLBR-1) for this newly emerging clinical entity.
Lechner MG; Lade S; Liebertz DJ; Prince HM; Brody GS; Webster HR; Epstein AL
Cancer; 2011 Apr; 117(7):1478-89. PubMed ID: 21425149
[TBL] [Abstract][Full Text] [Related]
3. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
[TBL] [Abstract][Full Text] [Related]
4. ALK-1-negative anaplastic large cell lymphoma associated with breast implants: a new clinical entity.
Lazzeri D; Agostini T; Bocci G; Giannotti G; Fanelli G; Naccarato AG; Danesi R; Tuccori M; Pantaloni M; D'Aniello C
Clin Breast Cancer; 2011 Oct; 11(5):283-96. PubMed ID: 21729665
[TBL] [Abstract][Full Text] [Related]
5. Anaplastic large cell lymphoma, ALK-positive.
Ferreri AJ; Govi S; Pileri SA; Savage KJ
Crit Rev Oncol Hematol; 2012 Aug; 83(2):293-302. PubMed ID: 22440390
[TBL] [Abstract][Full Text] [Related]
6. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
[TBL] [Abstract][Full Text] [Related]
7. Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.
Bohling SD; Jenson SD; Crockett DK; Schumacher JA; Elenitoba-Johnson KS; Lim MS
Leuk Res; 2008 Mar; 32(3):383-93. PubMed ID: 17720243
[TBL] [Abstract][Full Text] [Related]
8. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
[TBL] [Abstract][Full Text] [Related]
9. Consequences of heat shock protein 72 (Hsp72) expression and activity on stress-induced apoptosis in CD30+ NPM-ALK+ anaplastic large-cell lymphomas.
Bonvini P; Zorzi E; Mussolin L; Pillon M; Romualdi C; Peron M; d'Amore ES; Lamant L; Rosolen A
Leukemia; 2012 Jun; 26(6):1375-82. PubMed ID: 22289917
[TBL] [Abstract][Full Text] [Related]
10. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma.
Khoury JD; Medeiros LJ; Rassidakis GZ; Yared MA; Tsioli P; Leventaki V; Schmitt-Graeff A; Herling M; Amin HM; Lai R
Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3692-9. PubMed ID: 14506160
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F
Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657
[TBL] [Abstract][Full Text] [Related]
12. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma.
Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q
Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080
[TBL] [Abstract][Full Text] [Related]
13. Breast Implant and Anaplastic Large Cell Lymphoma Meta-Analysis.
Ramos-Gallardo G; Cuenca-Pardo J; Rodríguez-Olivares E; Iribarren-Moreno R; Contreras-Bulnes L; Vallarta-Rodríguez A; Kalixto-Sanchez M; Hernández C; Ceja-Martinez R; Torres-Rivero C
J Invest Surg; 2017 Feb; 30(1):56-65. PubMed ID: 27537783
[TBL] [Abstract][Full Text] [Related]
14. Anaplastic lymphoma kinase (ALK) positive anaplastic large cell lymphoma (ALCL) of breast in a patient without a breast implant.
Sathyanarayanan V; Lokesh KN; Lakshmaiah KC; Govind Babu K; Lokanatha D; Suresh Babu MC; Rao CR; Chennagiri P
Ann Saudi Med; 2014; 34(6):551-4. PubMed ID: 25971833
[TBL] [Abstract][Full Text] [Related]
15. Anaplastic large cell lymphoma (ALCL) and breast implants: breaking down the evidence.
Ye X; Shokrollahi K; Rozen WM; Conyers R; Wright P; Kenner L; Turner SD; Whitaker IS
Mutat Res Rev Mutat Res; 2014; 762():123-32. PubMed ID: 25475421
[TBL] [Abstract][Full Text] [Related]
16. Brefeldin A exerts differential effects on anaplastic lymphoma kinase positive anaplastic large cell lymphoma and classical Hodgkin lymphoma cell lines.
Toda T; Watanabe M; Kawato J; Kadin ME; Higashihara M; Kunisada T; Umezawa K; Horie R
Br J Haematol; 2015 Sep; 170(6):837-46. PubMed ID: 26105086
[TBL] [Abstract][Full Text] [Related]
17. Detection of a subset of CD30+ anaplastic large cell lymphoma by interphase fluorescence in situ hybridization.
Shin HJ; Thorson P; Gu J; Katz RL
Diagn Cytopathol; 2003 Aug; 29(2):61-6. PubMed ID: 12889041
[TBL] [Abstract][Full Text] [Related]
18. Genistein-induced apoptosis via Akt signaling pathway in anaplastic large-cell lymphoma.
Park SS; Kim YN; Jeon YK; Kim YA; Kim JE; Kim H; Kim CW
Cancer Chemother Pharmacol; 2005 Sep; 56(3):271-8. PubMed ID: 15883821
[TBL] [Abstract][Full Text] [Related]
19. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
[TBL] [Abstract][Full Text] [Related]
20. Anaplastic lymphoma kinase (ALK)-induced malignancies: novel mechanisms of cell transformation and potential therapeutic approaches.
Wasik MA; Zhang Q; Marzec M; Kasprzycka M; Wang HY; Liu X
Semin Oncol; 2009 Apr; 36(2 Suppl 1):S27-35. PubMed ID: 19393833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]